Pathology - Research and Practice, Год журнала: 2024, Номер 254, С. 155102 - 155102
Опубликована: Янв. 9, 2024
Язык: Английский
Pathology - Research and Practice, Год журнала: 2024, Номер 254, С. 155102 - 155102
Опубликована: Янв. 9, 2024
Язык: Английский
Pathology - Research and Practice, Год журнала: 2023, Номер 253, С. 155007 - 155007
Опубликована: Дек. 4, 2023
Язык: Английский
Процитировано
23Pathology - Research and Practice, Год журнала: 2023, Номер 251, С. 154880 - 154880
Опубликована: Окт. 11, 2023
Язык: Английский
Процитировано
16Pathology - Research and Practice, Год журнала: 2024, Номер 253, С. 155093 - 155093
Опубликована: Янв. 1, 2024
Язык: Английский
Процитировано
6Pathology - Research and Practice, Год журнала: 2023, Номер 252, С. 154947 - 154947
Опубликована: Ноя. 13, 2023
Язык: Английский
Процитировано
16Pathology - Research and Practice, Год журнала: 2023, Номер 252, С. 154949 - 154949
Опубликована: Ноя. 18, 2023
Язык: Английский
Процитировано
13Pathology - Research and Practice, Год журнала: 2024, Номер 253, С. 155087 - 155087
Опубликована: Янв. 1, 2024
Язык: Английский
Процитировано
4Current Issues in Molecular Biology, Год журнала: 2025, Номер 47(2), С. 88 - 88
Опубликована: Янв. 31, 2025
O. humifusa (Korean Cheonnyencho), a prickly pear cactus species, has garnered increased attention owing to its rich phytochemical composition and potential health benefits. In this study, the antioxidant anti-cancer activities of microwave-assisted aqueous extract derived from were investigated, content was characterized. High-performance liquid chromatography (HPLC) used identify various bioactive compounds, including polyphenols, flavonoids, other antioxidants known for their health-promoting properties. Furthermore, individual compounds in flavonoids separated using HPLC fractionation technique. The evaluated 2,2-diphenyl-1-picrylhydrazyl radical scavenging activity. results demonstrated significant activity extract, as evidenced by ability scavenge free radicals effectively reduce oxidized molecules. experiments involved treating colon cancer cells with varying concentrations (25 125 mg/mL) over 24-h period, resulting remarkable dose-dependent inhibition cell growth. Notably, inhibitory effect absent HDFa cells, highlighting selectivity targeting cells.
Язык: Английский
Процитировано
0Pathology - Research and Practice, Год журнала: 2023, Номер 253, С. 155023 - 155023
Опубликована: Дек. 10, 2023
Язык: Английский
Процитировано
10Pathology - Research and Practice, Год журнала: 2023, Номер 253, С. 155044 - 155044
Опубликована: Дек. 20, 2023
Язык: Английский
Процитировано
10Cancer Cell International, Год журнала: 2024, Номер 24(1)
Опубликована: Июнь 13, 2024
MicroRNA-98 (miR-98) stands as an important molecule in the intricate landscape of oncology. As a subset microRNAs, these small non-coding RNAs have accompanied new era cancer research, underpinning their significant roles tumorigenesis, metastasis, and therapeutic interventions. This review provides comprehensive insight into biogenesis, molecular properties, physiological undertakings miR-98, highlighting its double-edged role progression-acting both tumor promoter suppressor. Intriguingly, miR-98 has profound implications for various aspects progression, modulating key cellular functions, including proliferation, apoptosis, cell cycle. Given expression patterns, potential diagnostic prognostic biomarker, especially liquid biopsies tissues, is explored, emphasizing hurdles translating findings clinically. The concludes by evaluating avenues to modulate expression, addressing challenges therapy resistance, assessing efficacy In conclusion, while miR-98's involvement showcases promising avenues, future research should pivot towards understanding tumor-stroma interactions, immune modulation, metabolic regulation, thereby unlocking novel strategies management.
Язык: Английский
Процитировано
3